nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

01.03.2009 | Review Article

Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved

verfasst von: Markus Stenner, J. Peter Klussmann

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

This review aims to take stock of the new information that has accumulated over the past decade on the molecular pathology of salivary gland cancer. Emphasis will be placed on established and novel immunohistochemical markers, the pathways involved, and on findings of prognostic importance as well as new therapeutic concepts. Whenever reasonable, analogies to tumors of better explored, histologically related glandular organs such as pancreas and breast are established.

Vander Poorten VL (2002) Salivary gland carcinoma—stepping up the prognostic ladder. University of Amsterdam, Amsterdam, p 222

Barnes L, Eveson JW, Reichart P et al (eds) (2005) Tumors of the salivary gland. In: Pathology and genetics. Head and neck tumors. World health organization classification of tumors. IARC Press, Lyon, 209–281

Cheuk W, Chan JK (2007) Advances in salivary gland pathology. Histopathology 51(1):1–20PubMedCrossRef

Luukkaa H, Klemi P, Leivo I et al (2005) Salivary gland cancer in Finland 1991–96: an evaluation of 237 cases. Acta Otolaryngol 125(2):207–214PubMedCrossRef

Leivo I (2006) Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer. Acta Oncol 45(6):662–668. doi:10.1080/02841860600801316 PubMedCrossRef

Yamamoto T, Tanigawa N (2001) The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microsc 34:207–212. doi:10.1007/s007950100017 PubMedCrossRef

Schmitz M, Diestelkoetter P, Weigle B et al (2000) Generation of survivin-specific CD8CT effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res 60:4845–4849PubMed

Preuss SF, Weinell A, Molitor M et al (2008) Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. Br J Cancer 98(3):627–632PubMedCrossRef

Ben-Izhak O, Laster Z, Araidy S et al (2007) TUNEL—an efficient prognosis predictor of salivary malignancies. Br J Cancer 96(7):1101–1106PubMedCrossRef

10.

Nagler RM, Kerner H, Ben-Eliezer S et al (2003) Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies. Oncology 64(4):389–398. doi:10.1159/000070298 PubMedCrossRef

11.

Vonderheide RH, Hahn WC, Schultze JL et al (1999) The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 10:673–679. doi:10.1016/S1074-7613(00)80066-7 PubMedCrossRef

12.

Durkin AJ, Bloomston PM, Rosemurgy AS et al (2003) Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro. Am J Surg 186:431–436. doi:10.1016/j.amjsurg.2003.07.008 PubMedCrossRef

13.

Dodd RL, Slevin NJ (2006) Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42(8):759–769PubMedCrossRef

14.

Harding J, Burtness B (2005) Cetuximab: an epidermal growth factor receptor chimeric human-murine monoclonal antibody. Drugs Today (Barc) 41:107–127. doi:10.1358/dot.2005.41.2.882662 CrossRef

15.

Mimeault M, Brand RE, Sasson AA et al (2005) Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas 31(4):301–316PubMedCrossRef

16.

Vered M, Braunstein E, Buchner A (2002) Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 24:632–636. doi:10.1002/hed.10104 PubMedCrossRef

17.

Yancopoulos GD, Klagsbrun M, Folkman J (1998) Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 93(5):661–664PubMedCrossRef

18.

Lequerica-Fernández P, Astudillo A, de Vicente JC (2007) Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis. Anticancer Res 27(5B):3661–3666PubMed

19.

Cho KJ, Lee SS, Lee YS (1999) Proliferating cell nuclear antigen and C-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands. Head Neck 21:414–419 doi :10.1002/(SICI)1097-0347(199908)21:5<414::AID-HED6>3.0.CO;2-MPubMedCrossRef

20.

Skálová A, Starek I, Vanecek T et al (2003) Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by immunofluorescence in situ hybridization and immunohistochemistry. Histopathology 42:1–9. doi:10.1046/j.1365-2559.2003.01600.x CrossRef

21.

Skálová A, Starek , Kucerova V et al (2001) Salivary duct carcinoma–highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression. Pathol Res Pract 197:621–626. doi:10.1078/0344-0338-00136 PubMedCrossRef

22.

Etges A, Pinto DS Jr, Kowalski LP et al (2003) Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumor. J Clin Pathol 56(12):914–918PubMedCrossRef

23.

Jaehne M, Jäkel KT, Röser K et al (2001) About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands—a pilot-study. Laryngorhinootologie 80:525–529. doi:10.1055/s-2001-17088 PubMedCrossRef

24.

Jaehne M, Roeser K, Jaekel T et al (2005) Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103(12):2526–2533PubMedCrossRef

25.

Dong H, Bertler C, Schneider E et al (1997) Assessment of cell proliferation by AgNOR scores and Ki-67 labeling indices and a comparison with potential doubling times. Cytometry 28:280–288 doi :10.1002/(SICI)1097-0320(19970801)28:4<280::AID-CYTO2>3.0.CO;2-GPubMedCrossRef

26.

Pich A, Chiusa L, Navone R (2004) Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 15(9):1319–1329PubMedCrossRef

27.

Triantafillidou K, Dimitrakopoulos J, Iordanidis F et al (2006) Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature. Oral Dis 12(4):364–370PubMedCrossRef

28.

Skálová A, Lehtonen H, von Boguslawsky K et al (1994) Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 25(9):929–935. doi:10.1016/0046-8177(94)90014-0 PubMedCrossRef

29.

Kiyoshima T, Shima K, Kobayashi I et al (2001) Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 37(3):315–322. doi:10.1016/S1368-8375(00)00083-X PubMedCrossRef

30.

Luukkaa H, Klemi P, Leivo I et al (2006) Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases. Acta Oncol 45(6):669–675. doi:10.1080/02841860500543208 PubMedCrossRef

31.

Nordgard S, Franzen G, Boysen M et al (1997) Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 107(4):531–536. doi:10.1097/00005537-199704000-00019 PubMedCrossRef

32.

Hellquist HB, Sundelin K, Di Bacco A et al (1997) Tumor growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 181:323–329 doi :10.1002/(SICI)1096-9896(199703)181:3<323::AID-PATH780>3.0.CO;2-KPubMedCrossRef

33.

Bhattacharyya M, Lemoine NR (2006) Gene therapy developments for pancreatic cancer. Best Pract Res Clin Gastroenterol 20(2):285–298PubMedCrossRef

34.

Frierson HF Jr, El-Naggar AK, Welsh JB et al (2002) Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 161(4):1315–1323PubMed

35.

Lee TL, Yeh J, Friedman J et al (2008) A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Int J Cancer 122(9):1987–1998PubMedCrossRef

36.

Dong M, Nio Y, Yamasawa K et al (2003) p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. J Surg Oncol 82:111–120. doi:10.1002/jso.10186 PubMedCrossRef

37.

Yamamoto Y, Kishimoto Y, Virmani AK et al (1996) Mutations associated with carcinomas arising from pleomorphic adenomas of the salivary glands. Hum Pathol 27:782–786. doi:10.1016/S0046-8177(96)90449-9 PubMedCrossRef

38.

Yamada KM, Araki M (2001) Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 114:2375PubMed

39.

Tomozawa S, Tsuno NH, Sunami E et al (2000) Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer 83:324–328. doi:10.1054/bjoc.2000.1270 PubMedCrossRef

40.

Araki Y, Okamura S, Hussain SP et al (2003) Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 63:728–734PubMed

41.

Dori S, Trougouboff P, David R, Buchner A (2000) Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin. Oral Oncol 36:450–453. doi:10.1016/S1368-8375(00)00029-4 PubMedCrossRef

42.

Dimery IW, Jones LA, Verjan RP, Raymond AK, Goepfert H, Hong WK (1987) Estrogen receptors in normal salivary gland and salivary gland carcinoma. Arch Otolaryngol Head Neck Surg 113:1082–1085PubMed

43.

Jeannon JP, Soames JV, Bell H, Wilson JA (1999) Immunohistochemical detection of oestrogen and progesterone receptors in human salivary gland tumours. Clin Otolaryngol 24(1):52–54. doi:10.1046/j.1365-2273.1999.00211.x PubMedCrossRef

44.

Nasser SM, Faquin WC, Dayal Y (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 119(6):801–806. doi:10.1309/RVTP1G0Q727WJUQD PubMedCrossRef

45.

Ohshiro K, Rayala SK, Williams MD, Kumar R, El-Naggar AK (2006) Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells. Clin Cancer Res 12 (20 Pt 1):5994–5999CrossRef

46.

Yoshimura T, Sumida T, Liu S, Onishi A, Shintani S, Desprez PY, Hamakawa H (2007) Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment. Endocr Relat Cancer 14(4):1107–1116. doi:10.1677/erc.1.01253 PubMedCrossRef

47.

Jemal A, Murray T, Ward E et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30PubMedCrossRef

48.

Gaudernack G (2006) Prospects for vaccine therapy for pancreatic cancer. Best Pract Res Clin Gastroenterol 20(2):299–314PubMedCrossRef

49.

Campani D, Esposito I, Boggi U et al (2001) Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol 194(4):444–450PubMedCrossRef

50.

Friess H, Lu Z, Graber HU et al (1998) Bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut 43(3):414–421PubMedCrossRef

51.

Younes MN, Park YW, Yazici YD et al (2006) Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Mol Cancer Ther 5(11):2696–2705PubMedCrossRef

52.

Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344(11):783–792. doi:10.1056/NEJM200103153441101 PubMedCrossRef

53.

Agulnik M, Cohen EW, Cohen RB et al (2007) Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol 25(25):3978–3984PubMedCrossRef

54.

Piechocki MP, Yoo GH, Dibbley SK et al (2006) Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu. Int J Cancer 119(2):441–454PubMedCrossRef

55.

Hotte SJ, Winquist EW, Lamont E et al (2005) Imatinib mesylate in patients with adenoid cystic carcinoma of the salivary glands expressing c-kit: a Princess Margaret Hospital Phase II consortium study. J Clin Oncol 23(3):585–590. doi:10.1200/JCO.2005.06.125 PubMedCrossRef

56.

Ohta T, Nagakawa T, Tsukioka Y et al (1993) Expression of argyrophilic nucleolar organizer regions in ductal adenocarcinoma of the pancreas and its relationship to prognosis. Int J Pancreatol 13(3):193–200PubMed

57.

Ferrara C, Tessari G, Poletti A et al (1999) Ki-67 and c-jun expression in pancreatic cancer: a prognostic marker? Oncol Rep 6(5):1117–1122PubMed

58.

Niedergethmann M, Rexin M, Hidenbrand R et al (2002) Prognostic implication of routine, immunohistochemical and molecular staging in respectable pancreatic adenocarcinoma. Am J Surg Pathol 26:1578–1587. doi:10.1097/00000478-200212000-00005 PubMedCrossRef

59.

Stoll V, Calleja V, Vassaux G et al (2005) Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer. Gut 54(1):109–116PubMedCrossRef

60.

Yamamoto S, Tomita Y, Hoshida Y et al (2004) Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 10:2846–2850. doi:10.1158/1078-0432.CCR-02-1441 PubMedCrossRef

61.

Takeda A, Osaki M, Adachi K et al (2004) Role of the phosphatidylinositol 3′-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines. Pancreas 28:353–358. doi:10.1097/00006676-200404000-00026 PubMedCrossRef

62.

Hakam A, Fang Q, Karl R et al (2003) Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma. Dig Dis Sci 48(10):1972–1978PubMedCrossRef

63.

Coppola D (2000) Molecular prognostic markers in pancreatic cancer. Cancer Contr 7(5):421–427

64.

Toyonaga T, Nakano K, Nagano M et al (2003) Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. Cancer Lett 201:107–116. doi:10.1016/S0304-3835(03)00482-8 PubMedCrossRef

65.

Sun J, Blaskovich MA, Jove R et al (2005) Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24(20):3236–3245PubMedCrossRef

66.

Dergham ST, Dugan MC, Sarkar FH et al (1998) Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy. J Hepatobiliary Pancreat Surg 5(3):269–272. doi:10.1007/s005340050045 PubMedCrossRef

67.

Wilentz RE, Su GH, Dai JL et al (2000) Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinoma. Am J Pathol 156(1):37–43PubMed

68.

Feurino LW, Fisher WE, Bharadwaj U et al (2006) Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values. Cancer Invest 24(7):696–703PubMedCrossRef

69.

Le X, Shi Q, Wang B et al (2000) Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. J Interferon Cytokine Res 20:935. doi:10.1089/10799900050198372 PubMedCrossRef

70.

Shadaba A, Gaze MN, Grant HR (1997) The response of adenoid cystic carcinoma to tamoxifen. J Laryngol Otol 111(12):1186–1189. doi:10.1017/S0022215100139684 PubMedCrossRef

Titel: Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved
verfasst von: Markus Stenner
J. Peter Klussmann
Publikationsdatum: 01.03.2009
Verlag: Springer-Verlag
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 3/2009
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-008-0882-7

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved

Abstract

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Eingreifen von Umstehenden rettet vor Erstickungstod

Real-World-Daten sprechen eher für Dupilumab als für Op.

Schwindelursache: Massagepistole lässt Otholiten tanzen

Update HNO

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2009

Squamous cell carcinoma of the nasolacrimal duct

Detection of cytomegalovirus DNA in preserved umbilical cords from patients with sensorineural hearing loss

Cochlear implantation after surgery for bilateral jugular foramen paragangliomas: a case report

The comparison between two different combinations of alar cartilage-modifying techniques: is lateral crural steal the choice?

Cystic schwannoma of the cervical plexus masquerading as a type II second branchial cleft cyst

Association of laryngopharyngeal manifestations and gatroesophageal reflux

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Eingreifen von Umstehenden rettet vor Erstickungstod

Real-World-Daten sprechen eher für Dupilumab als für Op.

Schwindelursache: Massagepistole lässt Otholiten tanzen

Update HNO